Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma Comment uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lymphoma, Follicular

publication date

  • August 20, 2010

Research

keywords

  • Comment

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.28.9488

PubMed ID

  • 20566995

Additional Document Info

start page

  • e426; author reply e427

end page

  • 8

volume

  • 28

number

  • 24